Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Wonder developers eye emerging businesses and creatives for Troost
Business is brewing at the former Wonder Bread bakery. With a flurry of activity at 30th and Troost, the historic site is undergoing a transformation: from yet another vacant space on the corridor to an anchor for residential and commercial life on Troost. “They’ve gutted the inside and they’ve done a ton of work,” said…
You don’t have to pick a side, neighbor-led Troost Coalition says
It’s about bringing residents back to Troost Avenue, Cathryn Simmons said. And that means challenging the status quo. “This used to be a free-for-all. Troost was the Wild Wild West of Kansas City,” she said. “You could come over here and do anything you wanted. Legally.” A founding member of the Troost Coalition, Simmons helped…
Video: Nonprofit wants to bring coworking, craft fairs and farmers markets to Troost
Nonprofit group Troost Market Collective hopes to revitalize a section of Troost Avenue — from 31st to Linwood — bringing a coworking space, art collective and maker spaces, as well as regular festivals and farmers markets. While other developers are busy building residential and retail space along the Troost corridor, Troost Market Collective co-founders Katie Mabry…
Troost revival: Can a brewpub, retail and 670 housing units mend racial divide?
No turning back now, Ilan Salzberg said. “This is real,” the Wonder lofts developer laughed, gesturing at the freshly installed kitchen cabinetry and hardware in a model apartment unit at 30th Street and Troost Avenue. Wonder is expected to be the first of three major residential developments to open between 27th Street and Armour Boulevard…